INS and obesity due to melanocortin 4 receptor deficiency: It was also able to reverse β‐cell dysfunction promoted by incubation with the serum or plasma from obese subjects, indicating a therapeutic potential for this pathway in the prevention of insulin secretion failure in obesity.